| Catalog Number |
00505217300 |
| Medical Device Problem Code |
Packaging Problem (3007)
|
| Health Effect - Clinical Code |
No Consequences Or Impact To Patient (2199)
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
The reported device was returned to conmed for evaluation.A packaging engineer determined the sterility barrier was breached by the protective sleeve of the device.This report was verified and the likely cause of this packaging issue is the device was placed in the seal area during the manufacturing process.The manufacturing documents from the device history record have been reviewed with special attention to the manufacturing and inspection of this product.The products released for distribution were found to have met all specifications prior to shipment.This is the only complaint against this lot of (b)(4) units.A two-year historical complaint review revealed one similar complaint involving two devices.(b)(4).A risk analysis was performed and deemed acceptable.This reported packaging issue was obvious to the distributor, prompting the return of the device for evaluation.There was no patient involvement.As with all medical devices, examination of the product occurs multiple times prior to use.Good clinical practice would include examination and verification of the original packaging and its labeling to ensure both are intact.The instructions for use (ifu) provides the following warning.-if packaging has been opened/damaged or altered, do not use the product and contact the manufacturer immediately.This incident type will continue to be monitored through the complaint system to assure patient safety.
|
| |
|
Event or Problem Description
|
|
The distributor reported this 00505217300 blade was in the sealing area.This was found during incoming inspection, therefore, there was no patient contact.This complaint was reviewed and a regulatory rationale of "non-reportable" was documented.The reported device was returned to conmed and r and d determined by way of dye leak testing there was a breach in sterility on (b)(6) 2017.The regulatory rationale was updated to reflect the evaluation findings, deeming this a reportable event on 30-nov-2017.This report is raised on the basis of a reported malfunction with potential for injury with recurrence.
|
| |
|
Search Alerts/Recalls
|